Umur Hursever
Partner @ LGT group
London, United Kingdom
Umur Hursever is a Series C investor at LGT group in London focused on Medical and Health Care. Umur Hursever is Partner at Lightrock
- Total investments:
- 6
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Umur Hursever invests in
Stages Umur Hursever invests in
Countries Umur Hursever invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 2 (33%)
- Health Care 2 (33%)
- Robotics 1 (17%)
- Software 1 (17%)
- Medical Device 1 (17%)
Stage
- Series C 2 (33%)
- Series A 1 (17%)
- Series B 1 (17%)
- Series D 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Ultromics develops AI-powered software solutions to assist in cardiovascular disease diagnosis through echocardiography. The company provides platforms that support clinicians in interpreting echocardiogram data by applying machine learning to detect patterns and abnormalities that may indicate heart conditions. Ultromics offers its flagshipproduct, EchoGo, which automates the analysis of echocardiograms and delivers quantitative reports on cardiac function and structure. The software integrates with existing clinical workflows and is designed to enhance decision-making consistency while reducing variability in scan interpretation. Ultromics focuses on leveraging data-driven approaches to support early detection of conditions such as heart failure and coronary artery disease. Its technology is built on research collaborations and large-scale clinical datasets, aiming to improve diagnostic outcomes and support clinical efficiency. | $55M / Series C / Jul 31, 2025 | ||
| CMR Surgical develops and manufactures robotic surgical systems designed to enhance precision and efficiency in minimally invasive surgery. Its primary product, Versius, is a versatile and modular robotic system that supports various surgical procedures.Versius is designed to mimic the human arm's flexibility while offering a compact andergonomic design. It integrates with hospital workflows and provides data-driven insights to support surgical performance. CMR Surgical collaborates with healthcare professionals to ensure that its technology meets clinical needs and improves patient outcomes. | $163.9M / Series D / Sep 20, 2023 | ||
| CMR Surgical develops and manufactures robotic surgical systems designed to enhance precision and efficiency in minimally invasive surgery. Its primary product, Versius, is a versatile and modular robotic system that supports various surgical procedures.Versius is designed to mimic the human arm's flexibility while offering a compact andergonomic design. It integrates with hospital workflows and provides data-driven insights to support surgical performance. CMR Surgical collaborates with healthcare professionals to ensure that its technology meets clinical needs and improves patient outcomes. | $600M / Series D / Jun 28, 2021 | ||
| CMR Surgical develops and manufactures robotic surgical systems designed to enhance precision and efficiency in minimally invasive surgery. Its primary product, Versius, is a versatile and modular robotic system that supports various surgical procedures.Versius is designed to mimic the human arm's flexibility while offering a compact andergonomic design. It integrates with hospital workflows and provides data-driven insights to support surgical performance. CMR Surgical collaborates with healthcare professionals to ensure that its technology meets clinical needs and improves patient outcomes. | $240M / Series C / Sep 17, 2019 | ||
| CMR Surgical develops and manufactures robotic surgical systems designed to enhance precision and efficiency in minimally invasive surgery. Its primary product, Versius, is a versatile and modular robotic system that supports various surgical procedures.Versius is designed to mimic the human arm's flexibility while offering a compact andergonomic design. It integrates with hospital workflows and provides data-driven insights to support surgical performance. CMR Surgical collaborates with healthcare professionals to ensure that its technology meets clinical needs and improves patient outcomes. | $96.9M / Series B / Jun 04, 2018 | ||
| CMR Surgical develops and manufactures robotic surgical systems designed to enhance precision and efficiency in minimally invasive surgery. Its primary product, Versius, is a versatile and modular robotic system that supports various surgical procedures.Versius is designed to mimic the human arm's flexibility while offering a compact andergonomic design. It integrates with hospital workflows and provides data-driven insights to support surgical performance. CMR Surgical collaborates with healthcare professionals to ensure that its technology meets clinical needs and improves patient outcomes. | $26M / Series A / Sep 18, 2017 |
Co-Investors
About LGT group
LGT group is the private banking and asset management group of the princely House of Liechtenstein.
LGT group Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Max von und zu Liechtenstein
Chief Executive Officer
|
|||
Nina Kreyer
Global Head Learning and Development
|
|||
Alexander Burger
Relationship Manager
|
|||
Anthony Welterveden
Data Analytics
|
|||
|
Guido F.X.M. Nieuwenhuizen
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Umur Hursever invest in?
Umur Hursever invests primarily in Medical, Health Care and Robotics startups, most often at Series C and Series A stage. Most of the 6 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Umur Hursever?
Public channels for Umur Hursever include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Umur Hursever last invest?
The most recent investment recorded for Umur Hursever closed in Jul 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
